These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20394909)

  • 1. Molecular imaging of coronary inflammation: overcoming hurdles one at a time..
    Narula J; Chandrashekhar Y
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):448-50. PubMed ID: 20394909
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.
    Rogers IS; Nasir K; Figueroa AL; Cury RC; Hoffmann U; Vermylen DA; Brady TJ; Tawakol A
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):388-97. PubMed ID: 20394901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging inflammation in atherosclerosis another step forward.
    Shah PK
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1223-5. PubMed ID: 19833313
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin reduces persistent coronary arterial inflammation evaluated by serial ¹⁸fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease.
    Suda K; Tahara N; Honda A; Yoshimoto H; Kishimoto S; Kudo Y; Kaida H; Abe T; Ueno T; Fukumoto Y
    Int J Cardiol; 2015 Jan; 179():61-2. PubMed ID: 25464413
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular Imaging in Acute Aortic Syndrome: Lighting a Path to Better Risk Assessment.
    Tawakol A; Mezue KN
    JACC Cardiovasc Imaging; 2022 Jul; 15(7):1305-1307. PubMed ID: 35798406
    [No Abstract]   [Full Text] [Related]  

  • 6. Small animal positron emission tomography imaging and in vivo studies of atherosclerosis.
    Hag AM; Ripa RS; Pedersen SF; Bodholdt RP; Kjaer A
    Clin Physiol Funct Imaging; 2013 May; 33(3):173-85. PubMed ID: 23522010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging in acromegaly: should clinicians look carefully at developments in the field?
    Giustina A; Mazziotti G; Giubbini R
    Nucl Med Commun; 2014 Sep; 35(9):897-9. PubMed ID: 24942477
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Kim TN; Kim S; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):142-8. PubMed ID: 20061516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiobelled white blood cells or FDG for imaging on inflammation and infection?
    Signore A; Soroa VA; De Vries EF
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):23-5. PubMed ID: 19182724
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effectiveness research for molecular imaging.
    Graham MM
    J Comp Eff Res; 2012 Mar; 1(2):113-4. PubMed ID: 24237368
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of using molecular imaging methods with complex modern radiopharmaceuticals in neurooncology].
    Tiutin LA; Stanzhevskiĭ AA; Panfilenko AF; Kostenikov NA; Iliushchenko IuR
    Vopr Onkol; 2013; 59(4):421-7. PubMed ID: 24032214
    [No Abstract]   [Full Text] [Related]  

  • 12. 18FDG PET and ultrasound echolucency in carotid artery plaques.
    Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory coronary ectasia identified by three-dimensional volume rendering of 18F-Fluorodeoxyglucose PET/CT.
    Park EJ; Lee S; Nam HS; Oh DJ; Kim JB; Yoo H; Kim JW
    EuroIntervention; 2017 Jun; 13(2):e227. PubMed ID: 28579558
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
    Kai H
    Geriatr Gerontol Int; 2010 Jan; 10(1):1-8. PubMed ID: 20102376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis.
    Tahara N; Imaizumi T; Virmani R; Narula J
    J Nucl Med; 2009 Mar; 50(3):331-4. PubMed ID: 19223412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new FDG brain revolution: the neurovascular unit and the default network.
    Sestini S; Castagnoli A; Mansi L
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):913-6. PubMed ID: 20033155
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute coronary syndrome in Takayasu arteritis without elevation of acute phase parameters.
    Ahmadi-Simab K; Hellmich B; Holl-Ulrich K; Fleischmann C; Dourvos O; Gross WL
    Rheumatology (Oxford); 2007 Mar; 46(3):554-5. PubMed ID: 17244668
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.
    Goldsmith SJ; Vallabhajosula S
    Semin Nucl Med; 2009 Jan; 39(1):2-10. PubMed ID: 19038596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning.
    Goethals I; Smeets P; De Winter O; Noens L
    Clin Nucl Med; 2006 Aug; 31(8):497-8. PubMed ID: 16855443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.